Prostaglandin E2 receptors in bone formation

International Orthopaedics

Volumn 31, Issue 6, 2007, Pages 767-772

  Li, M ^a   Thompson, D D ^a   Paralkar, V M ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 [3 HYDROXY 2 [3 HYDROXY 4 (3 METHOXYMETHYLPHENYL) 1 BUTENYL] 5 OXOCYCLOPENTYL] 5 THIAHEPTANOIC ACID METHYL ESTER; AE 1329; BONE MORPHOGENETIC PROTEIN 2; CP 533536; CP 734432; OSTEOCLAST DIFFERENTIATION FACTOR; POLYGLACTIN; PROSTAGLANDIN E; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTAGLANDIN E4; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANGIOGENESIS; BONE REMODELING; CALLUS; CONTINUOUS INFUSION; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FRACTURE HEALING; HYPOTENSION; KNOCKOUT MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE;

ANIMALS; DINOPROSTONE; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; OSTEOGENESIS; RATS; RECEPTORS, PROSTAGLANDIN E;

EID: 36349018290     PISSN: 03412695     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00264-007-0406-x     Document Type: Review

References (26)

1. 2 knockout mice. Bone 29:121-125
2. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Ann Rev Pharmacol Toxicol 41:661-690
3. Dekel S, Lenthall G, Francis MJ (1981) Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits. J Bone Joint Surg Br 63:185-189
4. Hartke JR, Lundy MW (2001) Bone anabolic therapy with selective prostaglandin analogs. J Musculoskel Neuron Inteact 2:25-31
5. Kamoshita E, Ikeda Y, Fujita M, Amano H, Oikawa A, Suzuki T, Ogawa Y, Yamashina S, Azuma S, Narumiya S, Unno N, Majima M (2006) Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis. Am J Pathology 169:1458-1472
6. Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG (1995) The role of prostaglandins in the regulation of bone metabolism. Clinical Orthop Rel Res 313:36-46
7. Ke HZ, Crawford DT, Qi H, Simmons HA, Owen TA, Paralkar VM, Li M, Lu B, Grasser WA, Cameron KO, Lefker BA, DaSilva-Jardine P, Scott DO, Zhang Q, Tian XY, Jee WSS, Brown TA, Thompson DD (2006) A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats. J Bone Mineral Res 21:565-575
8. Keller J, Bünger C, Andreassen TT, Bak B, Lucht U (1987) Bone repair inhibited by indomethacin. Effects on bone metabolism and strength of rabbit osteotomies. Acta Orthop Scand 58:379-383
9. 2 on callus in rabbit osteotomy. Eur J Exp Musculoskeletal Res 1:86-92
10. Li M, Ke HZ, Qi H, Healy DR, Li Y, Crawford DT, Paralkar VM, Owen TA, Cameron KO, Lefker BA, Brown TA, Thompson DD (2003) A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 18:2033-2042
11. Li M, Healy DR, Li Y, Simmons HA, Crawford DT, Ke HZ, Pan LC, Brown TA, Thompson DD (2005) Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Bone 37:46-54
12. 2 receptor impairs osteoclastogenesis in vitro. Endocrinology 141:2054-2061
13. 2. Mol Pharmacol 60:36-41
14. 2 EP4 receptor-selective agonist facilitates sternal healing after harvesting bilateral internal thoracic arteries in diabetic rats. J Thorac Cardiovasc Surg 131:587-593
15. 1: quantitative histomorphometry and comparison of delivery by minipumps and controlled-release pellets. Bone 14:143-151
16. 2 in prostaglandin E receptor EP4-knockout mice. J Bio Chem 276:19819-19823
17. Pan LC, Crawford DT, Simmons HA, McCurdy SP, Nguyen MT, Tilley S, Koller HB, Ke HZ (1998) Mouse lines lacking EP2 or EP4 prostaglandin receptor subtypes exhibit different bone phenotypes. Bone 23:S168
18. Pecina M, Giltaij L, Vukicevic S (2001) Orthopaedic applications of osteogenic protein-1 (BMP-7). Int Orthop 25:203-208
19. Paralkar VM, Borovecki F, Ke HZ, Cameron KO, Lefker BA, Grasser WA, Owen TA, Li M, DaSilva-Jardine P, Zhou M, Dunn RL, Dumont F, Korsmeyer R, Krasney P, Brown TA, Plowchalk D, Vukicevic S, Thompson DD (2003) An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci USA 100:6736-6740
20. Raisz LG, Woodiel FN (2003) Effects of selective prostaglandin EP2 and EP4 receptor agonists on bone resorption and formation in fetal rat organ cultures. Prostaglandins Other Lipid Mediat 71:287-292
21. Sakou T (1998) Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22:591-603
22. Tanaka M, Sakai A, Uchida S, Tanaka S, Nagashima M, Katayama T, Yamaguchi K, Nakamura T (2004) Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone 34:940-948
23. Voegeli TL, Chapman MW (1985) Utilization of prostaglandin in fracture healing. Trans Orthop Res Soc 10:134
24. 2) prevents renal damage and inhibits progression of renal disease in rodent models of acute and chronic kidney disease. Kidney Int 70:1099-1106
25. 2 in osteoblastic cell lines and adult rat bone tissue. Bone 28:275-281
26. Yoshida K, Oida H, Kobayashi T, Maruyama T, Tanada M, Katayama T, Yamaguchi K, Segi E, Tsubouama T, Matshushita M, Ito K, Ito Y, Sugimoto Y, Ushikubi F, Ohuchida S, Kondo K, Nakamura T, Narumiya S (2002) Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci USA 899:4580-4585